BASTIDE LE CONFORT MÉDICAL Bastide Le Confort Médical Stock BOERSE MUENCHEN
Equities
1DJ
FR0000035370
Healthcare Facilities & Services
|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.45 EUR | -1.61% |
|
-7.43% | -18.35% |
| May. 15 | BASTIDE LE CONFORT MEDICAL : De facto maintained guidance; more disposals to propel debt reduction |  |
| May. 15 | Bastide: 8.2% increase in quarterly sales | CF |
| Sales 2024 * | 529M 573M | Sales 2025 * | 560M 606M | Capitalization | 160M 173M |
|---|---|---|---|---|---|
| Net income 2024 * | 16M 17.34M | Net income 2025 * | 22M 23.84M | EV / Sales 2024 * | 0.93 x |
| Net Debt 2024 * | 333M 361M | Net Debt 2025 * | 328M 355M | EV / Sales 2025 * | 0.87 x |
| P/E ratio 2024 * |
9.46
x | P/E ratio 2025 * |
7
x | Employees | - |
| Yield 2024 * |
2.18% | Yield 2025 * |
2.66% | Free-Float | 44.91% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 week | -7.43% | ||
| 1 month | +19.78% | ||
| 3 months | +18.35% | ||
| Current year | -18.35% |
1 week
21.45
23.55
1 month
18.2023.55
| Managers | Title | Age | Since |
|---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
| Corporate Officer/Principal | 50 | 15-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Vanessa Giraud
BRD | Director/Board Member | 50 | - |
Olivier Mares
BRD | Director/Board Member | 47 | 19-07-17 |
| Date | Price | Change |
|---|---|---|
| 24-06-03 | 21.45 | -1.61% |
| 24-05-31 | 21.8 | -3.11% |
| 24-05-30 | 22.5 | -1.10% |
| 24-05-29 | 22.75 | 0.00% |
| 24-05-28 | 22.75 | -1.09% |
Real-time BOERSE MUENCHEN, June 03, 2024 at 05:13 am EDT
More quotes
Bastide Le Confort Médical specializes in home health services for the elderly, ill, and handicapped. The activity is organized around three families of products and services:
- home care equipment and services: hospital beds, personal assistance products, etc.;
- respiratory assistance equipment and services: mainly respirators, oxygen concentrators, and oxygen tanks;
- perfusion and nutrition equipment and services: perfusion, nutrition, and insulin pumps and syringe-drivers.
Net sales break down by source of income into sales of services (56.6%; rental, installation, and maintenance services) and sales of equipment and consumables (43.4%).
France accounts for 82,2% of net sales.
Calendar
2024-08-28
- Q4 2024 Sales and Revenue Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
21.6
EUR
Average target price
30.17
EUR
Spread / Average Target
+39.66%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -4.11% | 2.98B | |
| -.--% | 1.93B | |
| +23.65% | 1.86B | |
| +69.11% | 707M | |
| -11.21% | 461M | |
| -16.05% | 131M | |
| 0.00% | 67.77M |
- Stock Market
- Equities
- BLC Stock
- 1DJ Stock
